F. BLAINE HOLLINGER to Hepatitis C
This is a "connection" page, showing publications F. BLAINE HOLLINGER has written about Hepatitis C.
Connection Strength
1.312
-
GSK-3? as a Potential Coordinator of Anabolic and Catabolic Pathways in Hepatitis C Virus Insulin Resistance. Intervirology. 2024; 67(1):6-18.
Score: 0.681
-
Hepatitis C virus (HCV) occult infection or occult HCV RNA detection? J Infect Dis. 2004 Jan 01; 189(1):3-6.
Score: 0.171
-
Factors contributing to the evolution and outcome of cirrhosis in hepatitis C. Clin Liver Dis. 1999 Nov; 3(4):741-55, viii.
Score: 0.128
-
Improved methods for quantification of human immunodeficiency virus type 1 RNA and hepatitis C virus RNA in blood using spin column technology and chemiluminescent assays of PCR products. J Med Virol. 1997 Jan; 51(1):56-63.
Score: 0.105
-
Polymerase chain reaction assay for hepatitis C virus RNA using a single tube for reverse transcription and serial rounds of amplification with nested primer pairs. J Med Virol. 1992 Nov; 38(3):220-5.
Score: 0.079
-
Epidemiology and transmission of hepatitis B and C viruses in Kazakhstan. World J Gastroenterol. 2007 Feb 28; 13(8):1204-7.
Score: 0.053
-
Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein. Virology. 2006 Apr 10; 347(2):466-75.
Score: 0.049
-
Detection of antibodies to hepatitis C virus in seronegative patients using an immune complex dissociation assay. J Viral Hepat. 1997; 4(6):383-6.
Score: 0.026
-
A multicenter study of viral hepatitis in a United States hemophilic population. Blood. 1993 Jan 15; 81(2):412-8.
Score: 0.020